Sublingual drops: once daily
Withdrawal Assessment Report Egrifta (tesamorelin)
Considering these changes in T2DM and the critical role of GLP-1 in glucose homeostasis, strategies for managing T2DM based on this hormone include addressing the differentiation of L-cells, increasing the endogenous production and secretion of GLP-1 through stimulants, extending the half-life of GLP-1 by inhibiting its degrading enzyme and targeting GLP-1R using its agonists
Patients now have the option to receive a medication tailored to their specific needs, ensuring better outcomes and improved patient satisfaction
Its biological effects are mediated through the GLP-1 receptor (GLP-1R), a class B G proteincoupled receptor with seven transmembrane domains [19]
This multifaceted approach ensures a more stable and controlled blood sugar level, helping to mitigate the risks associated with diabetes, such as cardiovascular disease and kidney damage